查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1974194

外科海綿市場：依產品類型、材質、滅菌方法、應用、最終用戶和銷售管道分類－2026-2032年全球預測

Surgical Sponges Market by Product Type, Material, Sterilization Type, Application, End User, Sales Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，外科海綿市場價值將達到 8.9127 億美元，到 2026 年將成長至 9.6315 億美元，到 2032 年將達到 15.0196 億美元，年複合成長率為 7.74%。

主要市場統計數據
基準年 2025 8.9127億美元
預計年份：2026年 9.6315億美元
預測年份 2032 15.0196億美元
複合年成長率 (%) 7.74%

對外科海綿的基本要素進行策略概述：重點關注其臨床作用、供應鏈趨勢、監管重點以及影響產品決策的創新壓力。

手術海綿仍然是圍手術全期護理的重要組成部分，在各個外科專科中發揮止血、傷口管理和手術安全保障的作用。手術室和門診的廣泛應用源於臨床對可靠吸收劑的持續需求，這些吸收劑能夠在各種生理條件下提供可預測的性能。同時，感染控制、抗生素使用和病人安全等領域的進步，使得通訊協定的審查日益嚴格，迫使製造商重新評估材料配方和滅菌方法。

重大的結構性變化正在改變整個圍手術全期和門診醫療保健環境中的供應商行為、臨床偏好、消毒方法和分銷模式。

近年來，外科海綿領域發生了翻天覆地的變化，其意義遠不止於產品本身的改進。這些變化反映了醫療服務體系和風險管理的更廣泛轉變。首先，將感染預防要求納入採購決策，使得抗菌處理海綿和檢驗的滅菌方法成為至關重要的採購標準。其次，醫療服務模式向門診手術中心和門診治療室的轉變改變了使用習慣，要求供應商調整包裝尺寸、一次性使用規格和滅菌規範，以適應分散式醫療環境。

2025 年關稅環境如何重塑外科海綿供應鏈的成本和連續性方面的供應鏈策略、採購決策和採購實務。

2025年推出並加強的醫療設備進口關稅措施對整個外科海綿供應鏈的籌資策略、供應商選擇和成本結構產生了累積影響。由於關稅導致到岸成本增加，醫療器材採購部門和經銷商被迫重新評估其供應商組合，盡可能優先考慮區域採購，並重新談判長期合約以應對價格波動。在許多情況下，採購人員試圖在成本壓力和臨床需求之間取得平衡，因此會轉向那些在考慮關稅和物流因素後，能夠以更優惠的總交付成本提供同等臨床性能的材料和供應商。

詳細的細分分析表明，產品類型、材料、滅菌相容性、功能、應用、最終用戶和通路對需求趨勢的影響各不相同。

細分市場分析揭示了不同產品類型、材料、功能、滅菌方法、應用、最終用戶和銷售管道的性能預期和採購行為存在差異。在產品類型方面，複合材料結構通常定位於高性能應用，優先考慮吸水性、強度和保持/檢測性能；而非不織布布則優先考慮一次性使用、生產穩定性和成本效益。由於傳統偏好和重視傳統纖維特性的特定臨床細分市場，機織織物的需求依然強勁。材料選擇進一步區分了產品。棉花因其天然的吸水性和柔軟觸感而備受青睞，而聚酯和聚丙烯等合成基材則因其穩定的生產公差、快速大規模生產的潛力以及與特定滅菌方法的兼容性而被選中。

區域比較分析揭示了美洲、歐洲、中東和非洲以及亞太地區的基礎設施、法規和採購模式如何以不同的方式驅動臨床和商業性優先事項。

區域趨勢反映了不同的營運重點和基礎設施能力，這些因素影響部署模式和策略規劃。在美洲，對臨床性能和基於價值的採購的關注推動了對先進功能和即用型無菌包裝的需求。同時，分銷網路和國內滅菌能力支援大型醫療保健系統快速響應。在歐洲、中東和非洲，情況較為複雜，有些地區的監管協調與其他地區的產能限制並存。這導致對支援多種滅菌途徑且擁有完善供應鏈文件的產品需求不斷成長。

競爭對手的行為和策略重點透過創新、夥伴關係和品質體系，將領導企業、細分領域專家和區域參與者區分開來。

在企業層面，發展趨勢的特徵是創新、供應鏈韌性和不同的商業化策略。主要企業正將研發重點放在改進材料科學、整合抗菌劑以及開發便於追溯和滅菌驗證的包裝系統。同時，中型企業和新興企業通常憑藉其專業技術、區域夥伴關係關係或能夠快速回應滅菌方法要求和終端用戶偏好的靈活生產系統展開競爭。在法規環境下，為了降低供應連續性風險並加速市場准入，與滅菌服務供應商、分銷網路和臨床合作夥伴建立策略合作夥伴關係正變得越來越普遍。

為製造商和供應商提供可操作且優先的行動方案，以提高臨床適用性、供應彈性、監管準備和跨通路商業性可行性。

產業領導者應採取一系列平衡的舉措，以提高臨床可靠性、確保供應連續性並最佳化商業性覆蓋範圍。優先考慮能夠顯著提升臨床操作和殘留物檢測能力的材料和設計創新，將有助於實現顯著差異化，同時確保與多種滅菌方法相容，並擴大產品在各類醫療機構中的應用。加強與滅菌服務供應商和區域分銷商的合作關係，將減少對長途跨境物流的依賴，並提高應對關稅和物流因素造成的干擾的應對力。

我們將以透明的方式解釋我們多方面的調查方法，該方法結合了相關人員訪談、監管審查和產品比較分析，以確保獲得紮實的實踐知識。

本研究整合了多種資料收集方法，旨在建立嚴謹的證據基礎，同時保持研究限制和假設的透明度。主要調查包括對臨床相關人員、採購經理、滅菌服務供應商和分銷合作夥伴進行結構化訪談，以了解使用模式、採購因素以及對滅菌相容性的擔憂。次要調查則查閱了監管指南、臨床實踐建議、滅菌標準和供應商技術文檔，並透過三角驗證法對研究結果進行驗證，以檢驗產品性能聲明。

簡明扼要地整合了不斷發展的行業優先事項，展示了臨床要求、滅菌相容性和供應彈性如何融合併定義競爭優勢。

總之，在臨床安全優先事項、滅菌需求和供應鏈現實的驅動下，外科海綿市場正處於可操作的創新和營運調整階段。價值鏈上的各個相關人員都在積極回應，優先選擇兼具檢驗的性能、滅菌柔軟性和供應穩定性的產品。關稅和物流壓力正在加速在地化和多元化策略的實施，而終端用戶向門診護理的轉變則促使包裝、SKU和分銷通路策略進行重組。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 外科海綿市場：依產品類型分類

  • 複合材料
  • 不織布
  • 織物

第9章 外科海綿市場：依材料分類

  • 棉布
  • 合成纖維
    • 聚酯纖維
    • 聚丙烯

第10章：以滅菌方法分類的外科海綿市場

  • 環氧乙烷
  • 伽瑪射線滅菌
  • 蒸氣
    • 乾熱滅菌
    • 濕熱

第11章 外科海綿市場：依應用領域分類

  • 牙科
  • 外科
  • 創傷護理

第12章 外科海綿市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 醫院
    • 私人的
    • 民眾

第13章 外科海綿市場：依銷售管道分類

  • 直銷
  • 批發商
    • 醫療設備批發商
    • 藥品批發商
  • 電子商務
  • 零售藥房

第14章 外科海綿市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 外科海綿市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 外科海綿市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國外科海綿市場

第18章：中國外科海綿市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • 3M Company
  • Aspen Surgical Products
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • BSN medical GmbH
  • Cardinal Health, Inc.
  • ConvaTec Group Plc
  • Crosstex International, Inc
  • DeRoyal Industries, Inc.
  • Dynarex Corporation
  • Hollister Incorporated
  • Johnson & Johnson
  • Lohmann & Rauscher International GmbH & Co. KG
  • McKesson Corporation
  • Medline Industries, LP
  • Molnlycke Health Care AB
  • Owens & Minor, Inc.
  • Paul Hartmann AG
  • Smith & Nephew plc
  • Teleflex Incorporated
  • Winner Medical Co., Ltd.
  • Zhende Medical Co., Ltd.
Product Code: MRR-D97D8E0B50C0

The Surgical Sponges Market was valued at USD 891.27 million in 2025 and is projected to grow to USD 963.15 million in 2026, with a CAGR of 7.74%, reaching USD 1,501.96 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 891.27 million
Estimated Year [2026] USD 963.15 million
Forecast Year [2032] USD 1,501.96 million
CAGR (%) 7.74%

A strategic overview of surgical sponge fundamentals highlighting clinical roles, supply chain dynamics, regulatory focus, and innovation pressures shaping product decisions

Surgical sponges remain a fundamental component of perioperative care, supporting hemostasis, wound management, and procedural safety across surgical specialties. Their ubiquity in operating rooms and ambulatory settings is underpinned by continued clinical demand for reliable absorbent materials that perform predictably under diverse physiological conditions. In parallel, the evolving landscape of infection prevention, antimicrobial stewardship, and patient safety initiatives has raised scrutiny on product performance specifications and traceability protocols, driving manufacturers to re-evaluate material formulation and sterilization practices.

Supply chain complexity has intensified the need for resilient procurement strategies. Raw material sourcing, sterilization capacity, and distribution logistics influence availability and lead times in ways that extend beyond traditional procurement cycles. Regulatory agencies have increased the emphasis on device classification, labeling accuracy, and post-market surveillance, prompting stakeholders to align product design and quality systems with stricter compliance expectations. Consequently, innovation in product functionality, from antimicrobial treatments to advanced nonwoven constructions, is increasingly judged not only by clinical efficacy but also by manufacturability, sterilization compatibility, and supply continuity.

Major structural changes transforming supplier behavior, clinical preferences, sterilization practices, and distribution models across perioperative and outpatient care environments

Recent years have witnessed transformative shifts in the surgical sponge landscape that transcend incremental product changes and instead reflect broader shifts in healthcare delivery and risk management. First, the integration of infection-prevention imperatives into procurement decisions has elevated antimicrobial-treated sponges and validated sterilization pathways as decisive purchase criteria. Second, care migration toward ambulatory surgical centers and outpatient procedural suites has altered usage patterns, with suppliers adapting packaging sizes, single-use formats, and sterilization-ready configurations for decentralized settings.

Third, materials science advances have enabled hybrid constructions that balance absorbency, tensile strength, and visual contrast for retention detection. At the same time, concerns about supply chain resilience and regional sterilization capacity have incentivized manufacturers to localize certain production and sterilization steps, thereby shortening lead times and reducing cross-border risk. Moreover, regulatory scrutiny on labeling and traceability has prompted the adoption of enhanced tracking and documentation practices, which are increasingly incorporated into product development roadmaps. Collectively, these shifts are recalibrating how suppliers compete and collaborate with healthcare providers to meet operational efficiency and patient safety objectives.

How the 2025 tariff environment reshaped supply chain strategies, sourcing decisions, and procurement practices for cost and continuity in surgical sponge supply chains

The introduction and escalation of tariff measures in 2025 affecting medical device imports have had a cumulative impact on procurement strategies, supplier selection, and cost structures within the surgical sponge ecosystem. Tariff-driven increases in landed costs have compelled healthcare purchasers and distributors to reassess supplier portfolios, prioritize local or regional sourcing options where available, and renegotiate long-term agreements to absorb price volatility. In many instances, buyers have sought to balance cost pressures with clinical requirements by shifting toward materials or suppliers that offer similar clinical performance but more favorable total delivered costs when tariffs and logistics are considered.

Manufacturers with global supply chains have responded by diversifying raw material procurement, relocating elements of production closer to core markets, or investing in domestic sterilization capacity to mitigate tariff exposure. These adaptations have required capital allocation decisions and operational reconfiguration, particularly for companies that previously relied on fully integrated, cross-border supply chains. From the provider perspective, inventory management practices have evolved to include tariff risk as an explicit factor, prompting larger buffer inventories of critical items in certain contexts while accelerating adoption of standardized SKUs and consolidated sourcing to simplify customs and compliance.

In-depth segmentation perspectives exposing how product types, materials, sterilization compatibility, functionality, applications, end users, and channels differently influence demand dynamics

Segmentation insights reveal distinct performance expectations and procurement behaviors across product types, materials, functionality, sterilization methods, applications, end users, and sales channels. Within product type, composite constructions are frequently positioned for higher-performance applications where absorbency, strength, and retention-detection are prioritized, while nonwoven options emphasize disposability, consistent manufacturing, and cost efficiency; woven varieties continue to serve legacy preferences and specific clinical niches that value traditional textile properties. Material choices further differentiate offerings: cotton remains valued for natural absorbency and tactile properties, whereas synthetic substrates such as polyester and polypropylene are selected for consistent manufacturing tolerances, rapid scale-up potential, and compatibility with certain sterilization modalities.

Functionality segmentation underscores an increasing tilt toward antimicrobial treated sponges for high-risk procedures, with chlorhexidine-based and silver ion technologies deployed depending on compatibility with both tissue contact profiles and sterilization temperatures. Sterilization type considerations are central to product design, as ethylene oxide, gamma irradiation, and steam sterilization impose distinct material constraints; within steam sterilization, dry heat and moist heat variations influence sterilization validation and packaging choices. Application perspectives differentiate dental, surgical, and wound care usages, each demanding tailored size, absorbency, and handling features. End-user segmentation spans ambulatory surgical centers, clinics, and hospitals, with private and public hospital settings exhibiting different procurement cycles, tendering practices, and compliance requirements. Finally, sales channel distinctions highlight that direct contracts, distributor partnerships with medical or pharmaceutical wholesalers, ecommerce platforms, and retail pharmacies each present unique logistical and regulatory considerations that shape product configuration and commercial strategy.

A comparative regional analysis revealing how infrastructure, regulation, and procurement models in the Americas, Europe Middle East Africa, and Asia Pacific drive distinct clinical and commercial priorities

Regional dynamics display divergent operational priorities and infrastructure capacities that influence adoption patterns and strategic planning. In the Americas, emphasis on clinical performance and value-based procurement has spurred interest in advanced functionality and sterilization-ready packaging, while distribution networks and domestic sterilization capacity support faster response cycles for large health systems. Meanwhile, Europe, Middle East & Africa presents a heterogeneous landscape where regulatory harmonization in some jurisdictions coexists with capacity constraints in others, driving demand for products that accommodate multiple sterilization pathways and robust supply chain documentation.

Asia-Pacific exhibits significant variability between mature healthcare markets that pursue clinical innovation and rapidly developing systems focused on scaling access and cost efficiency. In many regional contexts, localization of manufacturing and partnerships with regional distributors have been effective strategies to address tariff exposure, local regulatory nuances, and logistics complexity. Across all regions, the interplay between regulatory expectations, sterilization infrastructure, and procurement models shapes both product design and go-to-market approaches, creating region-specific opportunity windows for manufacturers and suppliers who can align operational capabilities with local clinical and compliance needs.

Competitive company behaviors and strategic priorities that differentiate leaders, niche specialists, and regional players through innovation, partnerships, and quality systems

Company-level dynamics are characterized by differential approaches to innovation, supply chain resilience, and commercialization. Leading manufacturers focus R&D on material science improvements, antimicrobial integrations, and packaging systems that facilitate traceability and sterilization validation. At the same time, midsize and emerging players often compete through niche specialization, regional partnerships, or flexible manufacturing that can rapidly adapt to sterilization method requirements or end-user preferences. Strategic alliances with sterilization service providers, distribution networks, and clinical partners are increasingly common as companies seek to de-risk supply continuity and accelerate market access in regulated environments.

Commercial strategies vary, with some organizations prioritizing direct contracting and integrated services for large health systems, and others leveraging distributor networks and ecommerce channels to reach ambulatory and retail end users. Investment in quality management systems, regulatory affairs capabilities, and post-market surveillance infrastructure remains a differentiator, particularly in jurisdictions with evolving regulatory frameworks. Ultimately, competitive positioning is shaped by the ability to align product performance claims with validated sterilization compatibility, consistent supply, and robust documentation that supports clinical acceptance and procurement approval.

Practical and prioritized actions for manufacturers and suppliers to boost clinical alignment, supply resilience, regulatory readiness, and commercial execution across channels

Industry leaders should pursue a balanced set of actions that enhance clinical credibility, secure supply continuity, and optimize commercial reach. Prioritizing material and design innovations that demonstrably improve clinical handling and retention detection will create meaningful differentiation, while simultaneously ensuring compatibility with multiple sterilization modalities to broaden adoption across facility types. Strengthening relationships with sterilization service providers and regional distributors can reduce reliance on long cross-border flows and improve responsiveness to tariff- and logistics-driven disruptions.

Operationally, companies should enhance transparency and traceability across the supply chain to support tenders and regulatory inquiries, and they should invest in quality and regulatory affairs resources to smooth market access in diverse jurisdictions. Commercially, segment-specific go-to-market strategies that address the distinct needs of ambulatory centers, clinics, and hospital procurement committees will improve conversion and retention. Finally, establishing flexible packaging, SKU rationalization, and digital ordering capabilities can reduce complexity for procurement teams and support rapid fulfillment in decentralized care settings.

Transparent explanation of the multi-method research approach combining stakeholder interviews, regulatory review, and comparative product analysis to ensure robust and actionable insights

This research synthesis integrates multiple data-gathering methods to produce a rigorous evidence base while maintaining transparency about limitations and assumptions. Primary research included structured interviews with clinician stakeholders, procurement leaders, sterilization service providers, and distribution partners to capture usage patterns, procurement drivers, and sterilization compatibility concerns. Secondary research involved reviewing regulatory guidance, clinical practice advisories, sterilization standards, and supplier technical documentation to triangulate findings and validate product performance claims.

Analytical methods combined qualitative synthesis with comparative assessments of product features, sterilization compatibility, and commercial strategies. Where applicable, case examples and aggregated insights were used to illustrate common operational responses to supply chain disruptions, tariff impacts, and regional capacity constraints. Throughout, data integrity was prioritized by sourcing from regulatory and clinical literature, validated supplier specifications, and direct stakeholder testimonies. Limitations include variability in regional reporting standards and the evolving nature of regulatory guidance, which readers should consider when applying insights to local contexts.

Concise synthesis of the sector's evolving priorities showing how clinical requirements, sterilization compatibility, and supply resilience converge to define competitive advantage

In conclusion, the surgical sponge landscape is undergoing a period of pragmatic innovation and operational recalibration driven by clinical safety priorities, sterilization requirements, and supply chain realities. Stakeholders across the value chain are responding by prioritizing products that marry validated performance with sterilization flexibility and supply continuity. Tariff and logistics pressures have accelerated localization and diversification strategies, while end-user shifts toward ambulatory care have reframed packaging, SKU, and channel strategies.

Success in this environment will depend on the ability of manufacturers and suppliers to align technical claims with sterilization validations, to invest in resilient supply chain architectures, and to tailor commercial approaches to the needs of distinct end users and regions. For purchasers, the emphasis will increasingly be on documented performance, traceability, and reliable fulfillment. Taken together, these dynamics point toward a maturing sector where clinical, operational, and commercial priorities converge to define long-term competitive advantage.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Surgical Sponges Market, by Product Type

  • 8.1. Composite
  • 8.2. Nonwoven
  • 8.3. Woven

9. Surgical Sponges Market, by Material

  • 9.1. Cotton
  • 9.2. Synthetic
    • 9.2.1. Polyester
    • 9.2.2. Polypropylene

10. Surgical Sponges Market, by Sterilization Type

  • 10.1. Ethylene Oxide
  • 10.2. Gamma
  • 10.3. Steam
    • 10.3.1. Dry Heat
    • 10.3.2. Moist Heat

11. Surgical Sponges Market, by Application

  • 11.1. Dental
  • 11.2. Surgical
  • 11.3. Wound Care

12. Surgical Sponges Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Clinics
  • 12.3. Hospitals
    • 12.3.1. Private
    • 12.3.2. Public

13. Surgical Sponges Market, by Sales Channel

  • 13.1. Direct
  • 13.2. Distributors
    • 13.2.1. Medical Distributors
    • 13.2.2. Pharmaceutical Wholesalers
  • 13.3. Ecommerce
  • 13.4. Retail Pharmacies

14. Surgical Sponges Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Surgical Sponges Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Surgical Sponges Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Surgical Sponges Market

18. China Surgical Sponges Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. 3M Company
  • 19.6. Aspen Surgical Products
  • 19.7. B. Braun Melsungen AG
  • 19.8. Baxter International Inc.
  • 19.9. BSN medical GmbH
  • 19.10. Cardinal Health, Inc.
  • 19.11. ConvaTec Group Plc
  • 19.12. Crosstex International, Inc
  • 19.13. DeRoyal Industries, Inc.
  • 19.14. Dynarex Corporation
  • 19.15. Hollister Incorporated
  • 19.16. Johnson & Johnson
  • 19.17. Lohmann & Rauscher International GmbH & Co. KG
  • 19.18. McKesson Corporation
  • 19.19. Medline Industries, L.P.
  • 19.20. Molnlycke Health Care AB
  • 19.21. Owens & Minor, Inc.
  • 19.22. Paul Hartmann AG
  • 19.23. Smith & Nephew plc
  • 19.24. Teleflex Incorporated
  • 19.25. Winner Medical Co., Ltd.
  • 19.26. Zhende Medical Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SURGICAL SPONGES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SURGICAL SPONGES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SURGICAL SPONGES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SURGICAL SPONGES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SURGICAL SPONGES MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SURGICAL SPONGES MARKET SIZE, BY STERILIZATION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SURGICAL SPONGES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SURGICAL SPONGES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SURGICAL SPONGES MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SURGICAL SPONGES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL SURGICAL SPONGES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL SURGICAL SPONGES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES SURGICAL SPONGES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA SURGICAL SPONGES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SURGICAL SPONGES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SURGICAL SPONGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SURGICAL SPONGES MARKET SIZE, BY COMPOSITE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SURGICAL SPONGES MARKET SIZE, BY COMPOSITE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SURGICAL SPONGES MARKET SIZE, BY COMPOSITE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SURGICAL SPONGES MARKET SIZE, BY NONWOVEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SURGICAL SPONGES MARKET SIZE, BY NONWOVEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SURGICAL SPONGES MARKET SIZE, BY NONWOVEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SURGICAL SPONGES MARKET SIZE, BY WOVEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SURGICAL SPONGES MARKET SIZE, BY WOVEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SURGICAL SPONGES MARKET SIZE, BY WOVEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SURGICAL SPONGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SURGICAL SPONGES MARKET SIZE, BY COTTON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SURGICAL SPONGES MARKET SIZE, BY COTTON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SURGICAL SPONGES MARKET SIZE, BY COTTON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SURGICAL SPONGES MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SURGICAL SPONGES MARKET SIZE, BY SYNTHETIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SURGICAL SPONGES MARKET SIZE, BY SYNTHETIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SURGICAL SPONGES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SURGICAL SPONGES MARKET SIZE, BY POLYESTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SURGICAL SPONGES MARKET SIZE, BY POLYESTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SURGICAL SPONGES MARKET SIZE, BY POLYESTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SURGICAL SPONGES MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SURGICAL SPONGES MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SURGICAL SPONGES MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SURGICAL SPONGES MARKET SIZE, BY STERILIZATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SURGICAL SPONGES MARKET SIZE, BY ETHYLENE OXIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SURGICAL SPONGES MARKET SIZE, BY ETHYLENE OXIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SURGICAL SPONGES MARKET SIZE, BY ETHYLENE OXIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SURGICAL SPONGES MARKET SIZE, BY GAMMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SURGICAL SPONGES MARKET SIZE, BY GAMMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SURGICAL SPONGES MARKET SIZE, BY GAMMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SURGICAL SPONGES MARKET SIZE, BY STEAM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SURGICAL SPONGES MARKET SIZE, BY STEAM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SURGICAL SPONGES MARKET SIZE, BY STEAM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SURGICAL SPONGES MARKET SIZE, BY STEAM, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SURGICAL SPONGES MARKET SIZE, BY DRY HEAT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SURGICAL SPONGES MARKET SIZE, BY DRY HEAT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SURGICAL SPONGES MARKET SIZE, BY DRY HEAT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SURGICAL SPONGES MARKET SIZE, BY MOIST HEAT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SURGICAL SPONGES MARKET SIZE, BY MOIST HEAT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SURGICAL SPONGES MARKET SIZE, BY MOIST HEAT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SURGICAL SPONGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SURGICAL SPONGES MARKET SIZE, BY DENTAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SURGICAL SPONGES MARKET SIZE, BY DENTAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SURGICAL SPONGES MARKET SIZE, BY DENTAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SURGICAL SPONGES MARKET SIZE, BY SURGICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SURGICAL SPONGES MARKET SIZE, BY SURGICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SURGICAL SPONGES MARKET SIZE, BY SURGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SURGICAL SPONGES MARKET SIZE, BY WOUND CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SURGICAL SPONGES MARKET SIZE, BY WOUND CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SURGICAL SPONGES MARKET SIZE, BY WOUND CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SURGICAL SPONGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SURGICAL SPONGES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SURGICAL SPONGES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SURGICAL SPONGES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SURGICAL SPONGES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SURGICAL SPONGES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SURGICAL SPONGES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SURGICAL SPONGES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SURGICAL SPONGES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SURGICAL SPONGES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SURGICAL SPONGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SURGICAL SPONGES MARKET SIZE, BY PRIVATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SURGICAL SPONGES MARKET SIZE, BY PRIVATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SURGICAL SPONGES MARKET SIZE, BY PRIVATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SURGICAL SPONGES MARKET SIZE, BY PUBLIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SURGICAL SPONGES MARKET SIZE, BY PUBLIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SURGICAL SPONGES MARKET SIZE, BY PUBLIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SURGICAL SPONGES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SURGICAL SPONGES MARKET SIZE, BY DIRECT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL SURGICAL SPONGES MARKET SIZE, BY DIRECT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL SURGICAL SPONGES MARKET SIZE, BY DIRECT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SURGICAL SPONGES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SURGICAL SPONGES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SURGICAL SPONGES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SURGICAL SPONGES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SURGICAL SPONGES MARKET SIZE, BY MEDICAL DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SURGICAL SPONGES MARKET SIZE, BY MEDICAL DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL SURGICAL SPONGES MARKET SIZE, BY MEDICAL DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL SURGICAL SPONGES MARKET SIZE, BY PHARMACEUTICAL WHOLESALERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL SURGICAL SPONGES MARKET SIZE, BY PHARMACEUTICAL WHOLESALERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL SURGICAL SPONGES MARKET SIZE, BY PHARMACEUTICAL WHOLESALERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL SURGICAL SPONGES MARKET SIZE, BY ECOMMERCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL SURGICAL SPONGES MARKET SIZE, BY ECOMMERCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL SURGICAL SPONGES MARKET SIZE, BY ECOMMERCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SURGICAL SPONGES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL SURGICAL SPONGES MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL SURGICAL SPONGES MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL SURGICAL SPONGES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS SURGICAL SPONGES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS SURGICAL SPONGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS SURGICAL SPONGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS SURGICAL SPONGES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS SURGICAL SPONGES MARKET SIZE, BY STERILIZATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS SURGICAL SPONGES MARKET SIZE, BY STEAM, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS SURGICAL SPONGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS SURGICAL SPONGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS SURGICAL SPONGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS SURGICAL SPONGES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS SURGICAL SPONGES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA SURGICAL SPONGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA SURGICAL SPONGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA SURGICAL SPONGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA SURGICAL SPONGES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA SURGICAL SPONGES MARKET SIZE, BY STERILIZATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA SURGICAL SPONGES MARKET SIZE, BY STEAM, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA SURGICAL SPONGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA SURGICAL SPONGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA SURGICAL SPONGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA SURGICAL SPONGES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA SURGICAL SPONGES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA SURGICAL SPONGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA SURGICAL SPONGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA SURGICAL SPONGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA SURGICAL SPONGES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA SURGICAL SPONGES MARKET SIZE, BY STERILIZATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA SURGICAL SPONGES MARKET SIZE, BY STEAM, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA SURGICAL SPONGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA SURGICAL SPONGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA SURGICAL SPONGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA SURGICAL SPONGES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA SURGICAL SPONGES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPONGES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPONGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPONGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPONGES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPONGES MARKET SIZE, BY STERILIZATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPONGES MARKET SIZE, BY STEAM, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPONGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPONGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPONGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPONGES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPONGES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE SURGICAL SPONGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE SURGICAL SPONGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE SURGICAL SPONGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE SURGICAL SPONGES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE SURGICAL SPONGES MARKET SIZE, BY STERILIZATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE SURGICAL SPONGES MARKET SIZE, BY STEAM, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE SURGICAL SPONGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE SURGICAL SPONGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE SURGICAL SPONGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE SURGICAL SPONGES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE SURGICAL SPONGES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST SURGICAL SPONGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST SURGICAL SPONGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST SURGICAL SPONGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST SURGICAL SPONGES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST SURGICAL SPONGES MARKET SIZE, BY STERILIZATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST SURGICAL SPONGES MARKET SIZE, BY STEAM, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST SURGICAL SPONGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST SURGICAL SPONGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST SURGICAL SPONGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST SURGICAL SPONGES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST SURGICAL SPONGES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA SURGICAL SPONGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA SURGICAL SPONGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA SURGICAL SPONGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA SURGICAL SPONGES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA SURGICAL SPONGES MARKET SIZE, BY STERILIZATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA SURGICAL SPONGES MARKET SIZE, BY STEAM, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA SURGICAL SPONGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA SURGICAL SPONGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA SURGICAL SPONGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA SURGICAL SPONGES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA SURGICAL SPONGES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC SURGICAL SPONGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC SURGICAL SPONGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC SURGICAL SPONGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC SURGICAL SPONGES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC SURGICAL SPONGES MARKET SIZE, BY STERILIZATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC SURGICAL SPONGES MARKET SIZE, BY STEAM, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC SURGICAL SPONGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC SURGICAL SPONGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC SURGICAL SPONGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC SURGICAL SPONGES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC SURGICAL SPONGES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL SURGICAL SPONGES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN SURGICAL SPONGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN SURGICAL SPONGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN SURGICAL SPONGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN SURGICAL SPONGES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN SURGICAL SPONGES MARKET SIZE, BY STERILIZATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN SURGICAL SPONGES MARKET SIZE, BY STEAM, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN SURGICAL SPONGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN SURGICAL SPONGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN SURGICAL SPONGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN SURGICAL SPONGES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN SURGICAL SPONGES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 191. GCC SURGICAL SPONGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. GCC SURGICAL SPONGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. GCC SURGICAL SPONGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 194. GCC SURGICAL SPONGES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 195. GCC SURGICAL SPONGES MARKET SIZE, BY STERILIZATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. GCC SURGICAL SPONGES MARKET SIZE, BY STEAM, 2018-2032 (USD MILLION)
  • TABLE 197. GCC SURGICAL SPONGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. GCC SURGICAL SPONGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. GCC SURGICAL SPONGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 200. GCC SURGICAL SPONGES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 201. GCC SURGICAL SPONGES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION SURGICAL SPONGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION SURGICAL SPONGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION SURGICAL SPONGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION SURGICAL SPONGES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION SURGICAL SPONGES MARKET SIZE, BY STERILIZATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION SURGICAL SPONGES MARKET SIZE, BY STEAM, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION SURGICAL SPONGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION SURGICAL SPONGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION SURGICAL SPONGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION SURGICAL SPONGES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION SURGICAL SPONGES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS SURGICAL SPONGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS SURGICAL SPONGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS SURGICAL SPONGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS SURGICAL SPONGES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS SURGICAL SPONGES MARKET SIZE, BY STERILIZATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS SURGICAL SPONGES MARKET SIZE, BY STEAM, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS SURGICAL SPONGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS SURGICAL SPONGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS SURGICAL SPONGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS SURGICAL SPONGES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS SURGICAL SPONGES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 224. G7 SURGICAL SPONGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. G7 SURGICAL SPONGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. G7 SURGICAL SPONGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 227. G7 SURGICAL SPONGES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 228. G7 SURGICAL SPONGES MARKET SIZE, BY STERILIZATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. G7 SURGICAL SPONGES MARKET SIZE, BY STEAM, 2018-2032 (USD MILLION)
  • TABLE 230. G7 SURGICAL SPONGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 231. G7 SURGICAL SPONGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. G7 SURGICAL SPONGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 233. G7 SURGICAL SPONGES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 234. G7 SURGICAL SPONGES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 235. NATO SURGICAL SPONGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 236. NATO SURGICAL SPONGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. NATO SURGICAL SPONGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 238. NATO SURGICAL SPONGES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 239. NATO SURGICAL SPONGES MARKET SIZE, BY STERILIZATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. NATO SURGICAL SPONGES MARKET SIZE, BY STEAM, 2018-2032 (USD MILLION)
  • TABLE 241. NATO SURGICAL SPONGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 242. NATO SURGICAL SPONGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. NATO SURGICAL SPONGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 244. NATO SURGICAL SPONGES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 245. NATO SURGICAL SPONGES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 246. GLOBAL SURGICAL SPONGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES SURGICAL SPONGES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES SURGICAL SPONGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES SURGICAL SPONGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES SURGICAL SPONGES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES SURGICAL SPONGES MARKET SIZE, BY STERILIZATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED STATES SURGICAL SPONGES MARKET SIZE, BY STEAM, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES SURGICAL SPONGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES SURGICAL SPONGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED STATES SURGICAL SPONGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES SURGICAL SPONGES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES SURGICAL SPONGES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA SURGICAL SPONGES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA SURGICAL SPONGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA SURGICAL SPONGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA SURGICAL SPONGES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA SURGICAL SPONGES MARKET SIZE, BY STERILIZATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. CHINA SURGICAL SPONGES MARKET SIZE, BY STEAM, 2018-2032 (USD MILLION)
  • TABLE 264. CHINA SURGICAL SPONGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 265. CHINA SURGICAL SPONGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 266. CHINA SURGICAL SPONGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 267. CHINA SURGICAL SPONGES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA SURGICAL SPONGES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)